Lataa...
Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis
Driven by access to better drugs, on average, newly diagnosed multiple myeloma patients have over 10 years overall survival. Using modern combination therapies – with or without the addition of high-dose melphalan and autologous stem cell transplantation – up to 80% of patients reach a complete resp...
Tallennettuna:
| Julkaisussa: | Bone Marrow Transplant |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5571752/ https://ncbi.nlm.nih.gov/pubmed/27595280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.222 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|